[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-study-detail:100528742":3},{"organization":4,"armGroups":7,"interventions":41,"overallOfficials":48,"centralContacts":53,"locations":62,"responsibleParty":285,"collaborators":47,"id":287,"slug":288,"hasResults":289,"nctId":290,"briefTitle":291,"officialTitle":292,"acronym":47,"eligibilityCriteria":293,"healthyVolunteers":289,"sex":294,"minAge":295,"maxAge":296,"enrollmentInfo":297,"targetDuration":47,"studyType":300,"phases":301,"briefSummary":303,"conditions":304,"keywords":307,"overallStatus":65,"whyStopped":47,"lastUpdateSubmitDate":314,"lastUpdatePostDateStruct":315,"startDateStruct":318,"completionDateStruct":320,"leadSponsor":322,"locationsCount":323},{"fullName":5,"class":6},"Verve Therapeutics, Inc.","INDUSTRY",[8,14,17,20,23,26,29,32,35,38],{"label":9,"type":10,"description":11,"interventionNames":12},"Cohort 1: Single Ascending Dose Escalation","EXPERIMENTAL","Participants will receive a single dose of VERVE-102.",[13],"Drug: VERVE-102",{"label":15,"type":10,"description":11,"interventionNames":16},"Cohort 2: Single Ascending Dose Escalation",[13],{"label":18,"type":10,"description":11,"interventionNames":19},"Cohort 3: Single Ascending Dose Escalation",[13],{"label":21,"type":10,"description":11,"interventionNames":22},"Cohort 4: Single Ascending Dose Escalation",[13],{"label":24,"type":10,"description":11,"interventionNames":25},"Cohort 5: Single Ascending Dose Escalation",[13],{"label":27,"type":10,"description":11,"interventionNames":28},"Cohort 6: Single Ascending Dose Escalation",[13],{"label":30,"type":10,"description":11,"interventionNames":31},"Cohort 7: Single Ascending Dose Escalation",[13],{"label":33,"type":10,"description":11,"interventionNames":34},"Cohort 8: Single Ascending Dose Escalation",[13],{"label":36,"type":10,"description":11,"interventionNames":37},"Cohort 9: Single Fixed Dose",[13],{"label":39,"type":10,"description":11,"interventionNames":40},"Cohort 10: Single Fixed Dose",[13],[42],{"type":43,"name":44,"description":45,"armGroupLabels":46,"otherNames":47},"DRUG","VERVE-102","Intravenous (IV) infusion",[39,9,15,18,21,24,27,30,33,36],null,[49],{"name":50,"affiliation":51,"role":52},"Call 1-877-CTLILLY (1-877-285-4559) or 1-317-615-4559 Mon - Fri 8 AM - 8 PM Eastern time (UTC\u002FGMT - 5 hours, EST)","Eli Lilly and Company","STUDY_DIRECTOR",[54,59],{"name":55,"role":56,"phone":57,"phoneExt":47,"email":58},"Trial questions or participation questions: 1-877-CTLILLY (1-877-285-4559) or","CONTACT","317-615-4559","LillyTrials@Lilly.com",{"name":60,"role":56,"phone":47,"phoneExt":47,"email":61},"Physicians interested in becoming principal investigators please contact","clinical_inquiry_hub@lilly.com",[63,77,86,95,103,111,120,129,138,147,156,165,172,179,188,195,202,209,216,223,232,241,250,257,264,271,278],{"facility":64,"status":65,"city":66,"state":67,"zip":68,"country":69,"countryCode":70,"cosmosGeoPoint":71,"geoPoint":76,"contacts":47},"Clinical Study Center","RECRUITING","Dothan","Alabama","36305","United States","US",{"type":72,"coordinates":73},"Point",[74,75],-85.39049,31.22323,{"lat":75,"lon":74},{"facility":64,"status":65,"city":78,"state":79,"zip":80,"country":69,"countryCode":70,"cosmosGeoPoint":81,"geoPoint":85,"contacts":47},"Pomona","California","91768",{"type":72,"coordinates":82},[83,84],-117.75228,34.05529,{"lat":84,"lon":83},{"facility":64,"status":65,"city":87,"state":88,"zip":89,"country":69,"countryCode":70,"cosmosGeoPoint":90,"geoPoint":94,"contacts":47},"Boca Raton","Florida","33434",{"type":72,"coordinates":91},[92,93],-80.0831,26.35869,{"lat":93,"lon":92},{"facility":64,"status":65,"city":96,"state":88,"zip":97,"country":69,"countryCode":70,"cosmosGeoPoint":98,"geoPoint":102,"contacts":47},"Jacksonville","32216",{"type":72,"coordinates":99},[100,101],-81.65565,30.33218,{"lat":101,"lon":100},{"facility":64,"status":65,"city":104,"state":88,"zip":105,"country":69,"countryCode":70,"cosmosGeoPoint":106,"geoPoint":110,"contacts":47},"Winter Park","32789",{"type":72,"coordinates":107},[108,109],-81.33924,28.6,{"lat":109,"lon":108},{"facility":64,"status":65,"city":112,"state":113,"zip":114,"country":69,"countryCode":70,"cosmosGeoPoint":115,"geoPoint":119,"contacts":47},"Indianapolis","Indiana","46237",{"type":72,"coordinates":116},[117,118],-86.15804,39.76838,{"lat":118,"lon":117},{"facility":64,"status":65,"city":121,"state":122,"zip":123,"country":69,"countryCode":70,"cosmosGeoPoint":124,"geoPoint":128,"contacts":47},"High Point","North Carolina","27260",{"type":72,"coordinates":125},[126,127],-80.00532,35.95569,{"lat":127,"lon":126},{"facility":64,"status":65,"city":130,"state":131,"zip":132,"country":69,"countryCode":70,"cosmosGeoPoint":133,"geoPoint":137,"contacts":47},"Philadelphia","Pennsylvania","19104",{"type":72,"coordinates":134},[135,136],-75.16362,39.95238,{"lat":136,"lon":135},{"facility":64,"status":65,"city":139,"state":140,"zip":141,"country":69,"countryCode":70,"cosmosGeoPoint":142,"geoPoint":146,"contacts":47},"DeSoto","Texas","75115",{"type":72,"coordinates":143},[144,145],-96.85695,32.58986,{"lat":145,"lon":144},{"facility":64,"status":65,"city":148,"state":149,"zip":150,"country":69,"countryCode":70,"cosmosGeoPoint":151,"geoPoint":155,"contacts":47},"Renton","Washington","98057",{"type":72,"coordinates":152},[153,154],-122.21707,47.48288,{"lat":154,"lon":153},{"facility":64,"status":65,"city":157,"state":47,"zip":47,"country":158,"countryCode":159,"cosmosGeoPoint":160,"geoPoint":164,"contacts":47},"Adelaide","Australia","AU",{"type":72,"coordinates":161},[162,163],138.59863,-34.92866,{"lat":163,"lon":162},{"facility":64,"status":65,"city":166,"state":47,"zip":47,"country":158,"countryCode":159,"cosmosGeoPoint":167,"geoPoint":171,"contacts":47},"Melbourne",{"type":72,"coordinates":168},[169,170],144.96332,-37.814,{"lat":170,"lon":169},{"facility":64,"status":65,"city":173,"state":47,"zip":47,"country":158,"countryCode":159,"cosmosGeoPoint":174,"geoPoint":178,"contacts":47},"Sydney",{"type":72,"coordinates":175},[176,177],151.20732,-33.86785,{"lat":177,"lon":176},{"facility":64,"status":65,"city":180,"state":47,"zip":47,"country":181,"countryCode":182,"cosmosGeoPoint":183,"geoPoint":187,"contacts":47},"Chicoutimi","Canada","CA",{"type":72,"coordinates":184},[185,186],-71.06369,48.41963,{"lat":186,"lon":185},{"facility":64,"status":65,"city":189,"state":47,"zip":47,"country":181,"countryCode":182,"cosmosGeoPoint":190,"geoPoint":194,"contacts":47},"Hamilton",{"type":72,"coordinates":191},[192,193],-79.84963,43.25011,{"lat":193,"lon":192},{"facility":64,"status":65,"city":196,"state":47,"zip":47,"country":181,"countryCode":182,"cosmosGeoPoint":197,"geoPoint":201,"contacts":47},"Montreal",{"type":72,"coordinates":198},[199,200],-73.58781,45.50884,{"lat":200,"lon":199},{"facility":64,"status":65,"city":203,"state":47,"zip":47,"country":181,"countryCode":182,"cosmosGeoPoint":204,"geoPoint":208,"contacts":47},"Québec",{"type":72,"coordinates":205},[206,207],-71.21454,46.81228,{"lat":207,"lon":206},{"facility":64,"status":65,"city":210,"state":47,"zip":47,"country":181,"countryCode":182,"cosmosGeoPoint":211,"geoPoint":215,"contacts":47},"Toronto",{"type":72,"coordinates":212},[213,214],-79.39864,43.70643,{"lat":214,"lon":213},{"facility":64,"status":65,"city":217,"state":47,"zip":47,"country":181,"countryCode":182,"cosmosGeoPoint":218,"geoPoint":222,"contacts":47},"Vancouver",{"type":72,"coordinates":219},[220,221],-123.11934,49.24966,{"lat":221,"lon":220},{"facility":64,"status":65,"city":224,"state":47,"zip":47,"country":225,"countryCode":226,"cosmosGeoPoint":227,"geoPoint":231,"contacts":47},"Rehovot","Israel","IL",{"type":72,"coordinates":228},[229,230],34.81199,31.89421,{"lat":230,"lon":229},{"facility":64,"status":65,"city":233,"state":47,"zip":47,"country":234,"countryCode":235,"cosmosGeoPoint":236,"geoPoint":240,"contacts":47},"Christchurch","New Zealand","NZ",{"type":72,"coordinates":237},[238,239],172.63333,-43.53333,{"lat":239,"lon":238},{"facility":64,"status":65,"city":242,"state":47,"zip":47,"country":243,"countryCode":244,"cosmosGeoPoint":245,"geoPoint":249,"contacts":47},"Birmingham","United Kingdom","UK",{"type":72,"coordinates":246},[247,248],-1.89983,52.48142,{"lat":248,"lon":247},{"facility":64,"status":65,"city":251,"state":47,"zip":47,"country":243,"countryCode":244,"cosmosGeoPoint":252,"geoPoint":256,"contacts":47},"Cambridge",{"type":72,"coordinates":253},[254,255],0.11667,52.2,{"lat":255,"lon":254},{"facility":64,"status":65,"city":258,"state":47,"zip":47,"country":243,"countryCode":244,"cosmosGeoPoint":259,"geoPoint":263,"contacts":47},"Edinburgh",{"type":72,"coordinates":260},[261,262],-3.19648,55.95206,{"lat":262,"lon":261},{"facility":64,"status":65,"city":265,"state":47,"zip":47,"country":243,"countryCode":244,"cosmosGeoPoint":266,"geoPoint":270,"contacts":47},"London",{"type":72,"coordinates":267},[268,269],-0.12574,51.50853,{"lat":269,"lon":268},{"facility":64,"status":65,"city":272,"state":47,"zip":47,"country":243,"countryCode":244,"cosmosGeoPoint":273,"geoPoint":277,"contacts":47},"Manchester",{"type":72,"coordinates":274},[275,276],-2.23743,53.48095,{"lat":276,"lon":275},{"facility":64,"status":65,"city":279,"state":47,"zip":47,"country":243,"countryCode":244,"cosmosGeoPoint":280,"geoPoint":284,"contacts":47},"Nottingham",{"type":72,"coordinates":281},[282,283],-1.15047,52.9536,{"lat":283,"lon":282},{"type":286,"investigatorFullName":47,"investigatorTitle":47,"investigatorAffiliation":47,"oldNameTitle":47,"oldOrganization":47},"SPONSOR","100528742","phase-1-a-study-of-verve-102-in-patients-with-familial-hypercholesterolemia-or-premature-coronary-artery-disease-100528742",false,"NCT06164730","A Study of VERVE-102 in Patients With Familial Hypercholesterolemia or Premature Coronary Artery Disease","Open-label, Phase 1b, Single Ascending Dose Study to Evaluate the Safety of VERVE-102 Administered to Patients With Heterozygous Familial Hypercholesterolemia or Premature Coronary Artery Disease Who Require Additional Lowering of Low-density Lipoprotein Cholesterol","Inclusion Criteria:\n\n* Diagnosis of HeFH or premature CAD\n\nExclusion Criteria:\n\n* Homozygous familial hypercholesterolemia\n* Active or history of chronic liver disease\n* Current treatment with PCSK9 inhibitor or prior treatment within specified timeframe\n* Clinically significant or abnormal laboratory values as defined by the protocol","ALL","18 Years","70 Years",{"count":298,"type":299},85,"ESTIMATED","INTERVENTIONAL",[302],"PHASE1","VT-10201 is an Open-label, Phase 1b, Single-ascending Dose Study That Will Evaluate the Safety of VERVE-102 Administered to Patients With Heterozygous Familial Hypercholesterolemia (HeFH) or Premature Coronary Artery Disease (CAD) Who Require Additional Lowering of LDL-C. VERVE-102 Uses Base-editing Technology Designed to Disrupt the Expression of the PCSK9 Gene in the Liver and Lower Circulating PCSK9 and LDL-C. This Study is Designed to Determine the Safety and Pharmacodynamic Profile of VERVE-102 in This Patient Population.",[305,306],"Heterozygous Familial Hypercholesterolemia","Premature Coronary Heart Disease",[44,308,309,310,311,312,313],"Familial Hypercholesterolemia","Coronary Artery Disease","Dose Escalation","Gene Editing","Base Editing","heart-2","2026-07-31",{"date":316,"type":317},"2026-08-03","ACTUAL",{"date":319,"type":317},"2024-04-30",{"date":321,"type":299},"2027-08",{"name":5,"class":6},27]